Eksempler på bruk av Mg loading dose på Engelsk og deres oversettelse til Norsk
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
A 750 mg loading dose is recommended on the first day of treatment with levetiracetam.
En støtdose på 750 mg anbefales Adult dose should be reduced to 25 mg every 12 hours following the 100 mg loading dose.
Dosen til voksne bør reduseres til 25 A single 200 mg loading dose should be administered on Day 1, followed by 100 mg daily thereafter.
En startdose på 200 mg bør gis Efient should be initiated with a single 60 mg loading dose and then continued at 10 mg once a day.
Efient skal innledes med en enkelt ladningsdose på 60 mg og deretter fortsettes med 10 A 6 mg loading dose contains up to 150 mg of alcohol which is equivalent to 3 mL beer or 1.25 mL wine.
En startdose på 6 mg inneholder opp til 150 Efient should be given as a single 60 mg loading dose and then continued at a 5 mg once daily dose. .
Efient bør gis som en enkelt ladningsdose på 60 mg, og deretter fortsettes med en dose If, after a careful individual benefit/risk evaluation by the prescribing physician(see section 4.4), treatment is deemed necessary in the patients age group≥ 75 years,then following a 60 mg loading dose a reduced maintenance dose of 5 mg should be prescribed.
Dersom det etter en nøye individuell nytte/risikovurdering av forskrivende lege(se pkt. 4.4) er ansett somnødvendig med behandling av pasientgruppen≥75 år, skal det etter en ladningsdose på 60 mg forskrives en redusert vedlikeholdsdose A single 70 mg loading dose should be administered on Day-1, followed by 50 mg daily thereafter.
En enkel startdose på 70 mg bør gis ST segment elevation acute myocardial infarction: clopidogrel should be given as a single daily dose of 75 mg initiated with a 300 mg loading dose in combination with ASA and with or without thrombolytics.
Akutt hjerteinfarkt med ST-segment elevasjon: klopidogrel bør gis som en daglig enkeltdose på 75 Patients received a 300 mg loading dose of clopidogrel(600 mg possible if having PCI) or 180 mg of ticagrelor.
Pasientene fikk 300 mg startdose med klopidogrel(600 In a 30-day study(ACCOAST) in 4033 patients with NSTEMI with elevated troponin who were scheduled for coronary angiography followed by PCI within 2 to 48 hours after randomization,subjects who received prasugrel 30 mg loading dose on average 4 hours prior to coronary angiography followed by a 30 mg loading dose at the time of PCI(n=2037) had an increased risk of non-CABG peri-procedural bleeding and no additional benefit compared to patients receiving a 60 mg loading dose at the time of PCI n=1996.
I en 30-dagers studie(ACCOAST) hos 4033 pasienter, med NSTEMI med forhøyet troponin, som gjennomgikk koronar angiografi etterfulgt av PCI innen 2 til 48 timer etter randomisering,hadde pasienter som fikk en 30 mg ladningsdose gjennomsnittlig 4 timer før koronar angiografi etterfulgt av en 30 mg ladningsdose ved tidspunkt for PCI(n=2037) en økt risiko for ikke-CABG blødninger relatert til prosedyre, samt ingen fordelaktig tilleggseffekt sammenlignet med pasienter som fikk 60 mg ladningsdose ved tidspunkt for PCI n=1996.Following a 60 mg loading dose of prasugrel, inhibition of ADP-induced platelet aggregation occurs at 15 minutes with 5 µM ADP and 30 minutes with 20 µM ADP.
Etter en ladningsdose på 60 mg prasugrel vil hemming av ADP-indusert plateaggregering skje etter 15 minutter med 5 µM ADP og etter 30 minutter med 20 µM ADP.Possia treatment should be initiated with a single 180 mg loading dose(two tablets of 90 mg) and then continued at 90 mg twice daily.
Behandlingen med Possia skal startes med én enkelt startdose på 180 mg(to 90 Clopidogrel(300 mg loading dose followed by 75 mg maintenance dose) did not show a pharmacokinetic interaction with rivaroxaban(15 mg) but a relevant increase in bleeding time was observed in a subset of patients which was not correlated to platelet aggregation, P-selectin or GPIIb/IIIa receptor levels.
Klopidogrel(300 mg initialdose etterfulgt av 75 In a clinical study of NSTEMI patients(the ACCOAST study), where patients were scheduled to undergo coronary angiography within 2 to 48 hours after randomization,patients given a 30 mg loading dose on average 4 hours prior to coronary angiography followed by a 30 mg loading dose at the time of PCI had an increased risk of non-CABG peri-procedural bleeding and no additional benefit compared to patients receiving a 60 mg loading dose at the time of PCI see sections 4.2 and 4.4.
I en klinisk studie ved NSTEMI(ACCOAST-studien) der pasientene gjennomgikk koronar angiografi innen 2 til 48 timer etter randomisering,hadde pasienter som fikk en 30 mg ladningsdose gjennomsnittlig 4 timer før koronar angiografi etterfulgt av en 30 Patients received clopidogrel(300 mg loading dose, followed by 75 mg/day, n=1,752) plus ASA or ASA alone(n=1,739),(150 to 325 mg as a loading dose, followed by 75 to 162 mg/day), a fibrinolytic agent and, when appropriate, heparin.
Pasientene fikk klopidogrel(300 mg startdose og deretter 75 mg/dag, n=1752)+ ASA eller ASA alene(n=1739),(150 In an interactionstudy with healthy volunteers, co-administration of clopidogrel(300 mg loading dose), a CYP2C8 inhibitor, increased repaglinide exposure(AUC0-∞) 5.1-fold and continued administration(75 mg daily dose) increased repaglinide exposure(AUC0-∞) 3.9-fold.
I en interaksjonsstudie med friske frivillige ble repaglinideksponering(AUC0-∞)økt 5,1 ganger ved samtidig administrasjon av klopidogrel(300 mg metningsdose(ladningsdose)), en CYP2C8-inhibitor, og repaglinideksponering(AUC0-∞) ble økt 3,9 ganger ved kontinuerlig administrasjon 75 Following administration of a 900 mg loading dose of clopidogrel(with ASA), 56 subjects with ACS were treated for 14 days with either prasugrel 10 mg once daily or clopidogrel 150 mg once daily, and then switched to either clopidogrel 150 mg or prasugrel 10 mg for another 14 days.
Etter administrering av en ladningsdose på 900 mg klopidogrel(sammen med ASA) ble 56 pasienter med ACS behandlet med enten prasugrel 10 Patients were randomised to clopidogrel(300 mg loading dose followed by 75 mg/day, N=6,259) plus ASA(75-325 mg once daily) or ASA alone(N=6,303),(75-325 mg once daily) and other standard therapies.
Pasientene ble randomisert til klopidogrel(300 mg startdose fulgt av 75 mg/dag, N=6259) i tillegg til ASA(75-325 mg/dag) eller ASA alene(N=6303),(75-325 mg/dag) og annen standardbehandling.Patients were randomised to clopidogrel(300 mg loading dose followed by 75 mg/day, N 6,259) or placebo(N 6,303), both given in combination with ASA(75-325 mg once daily) and other standard therapies.
Pasientene ble randomisert til klopidogrel(300 mg startdose fulgt av 75 mg/dag, N=6259) eller placebo(N=6303), begge gitt i kombinasjon med ASA(75-325 Patients received clopidogrel(300 mg loading dose, followed by 75 mg/day, n=1,752) or placebo(n=1,739), both in combination with ASA(150 to 325 mg as a loading dose, followed by 75 to 162 mg/day), a fibrinolytic agent and, when appropriate, heparin.
Pasientene fikk klopidogrel(300 mg startdose og deretter 75 mg/dag, n=1752) eller placebo(n=1739), begge i kombinasjon med ASA(150 Patients randomised to receive prasugrel(60 mg loading dose followed by 10 mg once daily) or clopidogrel(300 mg loading dose followed by 75 mg once daily) were treated for a median of 14.5 months maximum of 15 months with a minimum of 6 months follow-up.
Pasienter som ble randomisert til å få prasugrel(60 mg ladningsdose, etterfulgt av 10 
